Copyright Reports & Markets. All rights reserved.

Global Breast Cancer Liquid Biopsy Market Professional Survey Report 2019

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Circulating Tumor Cells (CTCs)
    • 1.4.3 Cell-Free DNA (CfDNA)
    • 1.4.4 Extracellular Vesicles (EVs)
    • 1.4.5 Other Circulating Biomarkers
  • 1.5 Market by Application
    • 1.5.1 Global Breast Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Diagnostic Centers
    • 1.5.4 Laboratories
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2015-2026)
  • 2.2 Global Breast Cancer Liquid Biopsy Growth Trends by Regions
    • 2.2.1 Breast Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Breast Cancer Liquid Biopsy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Breast Cancer Liquid Biopsy Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Breast Cancer Liquid Biopsy Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Breast Cancer Liquid Biopsy Players by Market Size
    • 3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2015-2020)
    • 3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Breast Cancer Liquid Biopsy Market Concentration Ratio
    • 3.2.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2019
  • 3.3 Breast Cancer Liquid Biopsy Key Players Head office and Area Served
  • 3.4 Key Players Breast Cancer Liquid Biopsy Product Solution and Service
  • 3.5 Date of Enter into Breast Cancer Liquid Biopsy Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2015-2020)
  • 4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Breast Cancer Liquid Biopsy Market Size (2015-2020)
  • 6.2 Breast Cancer Liquid Biopsy Key Players in North America (2019-2020)
  • 6.3 North America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 6.4 North America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Breast Cancer Liquid Biopsy Market Size (2015-2020)
  • 7.2 Breast Cancer Liquid Biopsy Key Players in Europe (2019-2020)
  • 7.3 Europe Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 7.4 Europe Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

8 China

  • 8.1 China Breast Cancer Liquid Biopsy Market Size (2015-2020)
  • 8.2 Breast Cancer Liquid Biopsy Key Players in China (2019-2020)
  • 8.3 China Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 8.4 China Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Breast Cancer Liquid Biopsy Market Size (2015-2020)
  • 9.2 Breast Cancer Liquid Biopsy Key Players in Japan (2019-2020)
  • 9.3 Japan Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 9.4 Japan Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Breast Cancer Liquid Biopsy Market Size (2015-2020)
  • 10.2 Breast Cancer Liquid Biopsy Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

11 India

  • 11.1 India Breast Cancer Liquid Biopsy Market Size (2015-2020)
  • 11.2 Breast Cancer Liquid Biopsy Key Players in India (2019-2020)
  • 11.3 India Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 11.4 India Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Breast Cancer Liquid Biopsy Market Size (2015-2020)
  • 12.2 Breast Cancer Liquid Biopsy Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 12.4 Central & South America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 QIAGEN
    • 13.1.1 QIAGEN Company Details
    • 13.1.2 QIAGEN Business Overview
    • 13.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction
    • 13.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2015-2020))
    • 13.1.5 QIAGEN Recent Development
  • 13.2 Roche Diagnostics
    • 13.2.1 Roche Diagnostics Company Details
    • 13.2.2 Roche Diagnostics Business Overview
    • 13.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction
    • 13.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.2.5 Roche Diagnostics Recent Development
  • 13.3 Bio-Rad Laboratories
    • 13.3.1 Bio-Rad Laboratories Company Details
    • 13.3.2 Bio-Rad Laboratories Business Overview
    • 13.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction
    • 13.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.3.5 Bio-Rad Laboratories Recent Development
  • 13.4 Myriad Genetics
    • 13.4.1 Myriad Genetics Company Details
    • 13.4.2 Myriad Genetics Business Overview
    • 13.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction
    • 13.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.4.5 Myriad Genetics Recent Development
  • 13.5 Menarini Silicon Biosystems
    • 13.5.1 Menarini Silicon Biosystems Company Details
    • 13.5.2 Menarini Silicon Biosystems Business Overview
    • 13.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction
    • 13.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.5.5 Menarini Silicon Biosystems Recent Development
  • 13.6 Genomic Health
    • 13.6.1 Genomic Health Company Details
    • 13.6.2 Genomic Health Business Overview
    • 13.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction
    • 13.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.6.5 Genomic Health Recent Development
  • 13.7 Thermo Fisher Scientific
    • 13.7.1 Thermo Fisher Scientific Company Details
    • 13.7.2 Thermo Fisher Scientific Business Overview
    • 13.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction
    • 13.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.7.5 Thermo Fisher Scientific Recent Development
  • 13.8 Illumina
    • 13.8.1 Illumina Company Details
    • 13.8.2 Illumina Business Overview
    • 13.8.3 Illumina Breast Cancer Liquid Biopsy Introduction
    • 13.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.8.5 Illumina Recent Development
  • 13.9 Biocept
    • 13.9.1 Biocept Company Details
    • 13.9.2 Biocept Business Overview
    • 13.9.3 Biocept Breast Cancer Liquid Biopsy Introduction
    • 13.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.9.5 Biocept Recent Development
  • 13.10 Trovagene
    • 13.10.1 Trovagene Company Details
    • 13.10.2 Trovagene Business Overview
    • 13.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction
    • 13.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 13.10.5 Trovagene Recent Development
  • 13.11 Guardant Health
    • 10.11.1 Guardant Health Company Details
    • 10.11.2 Guardant Health Business Overview
    • 10.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction
    • 10.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 10.11.5 Guardant Health Recent Development
  • 13.12 RainDance Technologies
    • 10.12.1 RainDance Technologies Company Details
    • 10.12.2 RainDance Technologies Business Overview
    • 10.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction
    • 10.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 10.12.5 RainDance Technologies Recent Development
  • 13.13 MDx Health
    • 10.13.1 MDx Health Company Details
    • 10.13.2 MDx Health Business Overview
    • 10.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction
    • 10.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 10.13.5 MDx Health Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Breast Cancer Liquid Biopsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    QIAGEN
    Roche Diagnostics
    Bio-Rad Laboratories
    Myriad Genetics
    Menarini Silicon Biosystems
    Genomic Health
    Thermo Fisher Scientific
    Illumina
    Biocept
    Trovagene
    Guardant Health
    RainDance Technologies
    MDx Health

    Market segment by Type, the product can be split into
    Circulating Tumor Cells (CTCs)
    Cell-Free DNA (CfDNA)
    Extracellular Vesicles (EVs)
    Other Circulating Biomarkers
    Market segment by Application, split into
    Hospitals
    Diagnostic Centers
    Laboratories

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now